$BNAI
Brand Engagement Network Inc.

2022 Q4 Form 10-K Financial Statement

#000119312523085720 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $824.2K $5.391M $2.313M
YoY Change -3.15% 133.07% 23029.3%
Operating Profit -$5.391M -$2.313M
YoY Change 133.07%
Interest Expense $2.618M $4.463M
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.480M $12.60M $7.391M
YoY Change -53.89% 70.45%
Pretax Income $3.273M $7.207M $5.078M
YoY Change 38.8% 41.92% -50879.2%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $3.273M $7.207M $5.078M
YoY Change 38.8% 41.92% -50879.2%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.08 $0.19 $152.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $212.6K $212.6K $861.5K
YoY Change -75.32% -75.32%
Cash & Equivalents $212.6K
Short-Term Investments
Other Short-Term Assets $63.03K $63.03K $388.7K
YoY Change -83.78% -83.78% 455.24%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $275.6K $275.6K $1.250M
YoY Change -77.95% -77.95% 1685.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $313.9M $313.9M $309.5M
YoY Change 1.44% 1.44%
Total Long-Term Assets $313.9M $313.9M $309.5M
YoY Change 1.44% 1.44%
TOTAL ASSETS
Total Short-Term Assets $275.6K $275.6K $1.250M
Total Long-Term Assets $313.9M $313.9M $309.5M
Total Assets $314.2M $314.2M $310.7M
YoY Change 1.12% 1.12% 443758.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.441M $5.441M $1.025M
YoY Change 431.01% 431.01%
Accrued Expenses $5.441M $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.441M $5.441M $1.025M
YoY Change 431.02% 431.01% 1949.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.00M $11.00M $19.13M
YoY Change -42.52% -42.52%
Total Long-Term Liabilities $11.00M $11.00M $19.13M
YoY Change -42.52% -42.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.441M $5.441M $1.025M
Total Long-Term Liabilities $11.00M $11.00M $19.13M
Total Liabilities $16.44M $16.44M $20.15M
YoY Change -18.45% -18.45% 40209.68%
SHAREHOLDERS EQUITY
Retained Earnings -$16.16M
YoY Change -14.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.16M $297.8M $290.5M
YoY Change
Total Liabilities & Shareholders Equity $314.2M $314.2M $310.7M
YoY Change 1.12% 1.12% 443758.37%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income $3.273M $7.207M $5.078M
YoY Change 38.8% 41.92% -50879.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$136.8K -$648.9K -$1.650M
YoY Change -2672.18% -60.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$309.5M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$309.5M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $312.5M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 312.0M
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -136.8K -648.9K -1.650M
Cash From Investing Activities 0.000 0.000 -309.5M
Cash From Financing Activities 0.000 0.000 312.0M
Net Change In Cash -136.8K -648.9K 861.5K
YoY Change 15.52% -175.32%
FREE CASH FLOW
Cash From Operating Activities -$136.8K -$648.9K -$1.650M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001838163
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
DHC ACQUISITION CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity File Number
EntityFileNumber
001-40130
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1541929
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
535 Silicon Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Southlake
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76092
CY2022 dei City Area Code
CityAreaCode
310
CY2022 dei Local Phone Number
LocalPhoneNumber
228-2894
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
303261706
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022 dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Shall Be Registered With Securities Exchange Commission
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesShallBeRegisteredWithSecuritiesExchangeCommission
P20D
CY2022 dhcau Number Of Days Related To Payment To Acquire Restricted Investment
NumberOfDaysRelatedToPaymentToAcquireRestrictedInvestment
P2D
CY2022 dhcau Number Of Days For Consummation Of Business Combination
NumberOfDaysForConsummationOfBusinessCombination
P10D
CY2022 dhcau Term Of Short Term Investments
TermOfShortTermInvestments
P3M
CY2022Q4 us-gaap Cash
Cash
212608
CY2021Q4 us-gaap Cash
Cash
861474
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1500
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
61530
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
388666
CY2022Q4 us-gaap Assets Current
AssetsCurrent
275638
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1250140
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
313913217
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
309450720
CY2022Q4 us-gaap Assets
Assets
314188855
CY2021Q4 us-gaap Assets
Assets
310700860
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5440933
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1024627
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5440933
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1024627
CY2022Q4 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
164410
CY2021Q4 dhcau Warrant Liabilities Non Current
WarrantLiabilitiesNonCurrent
8299434
CY2022Q4 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
10830775
CY2021Q4 dhcau Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
10830775
CY2022Q4 us-gaap Liabilities
Liabilities
16436118
CY2021Q4 us-gaap Liabilities
Liabilities
20154836
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
313913217
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
309450720
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16161254
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18905470
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-16160480
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18904696
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314188855
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310700860
CY2022 dhcau Operating And Formation Costs
OperatingAndFormationCosts
5390808
CY2021 dhcau Operating And Formation Costs
OperatingAndFormationCosts
2312931
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-5390808
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2312931
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8135024
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7977190
CY2022 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
586339
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
4462497
CY2021 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12597521
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7390851
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7206713
CY2021 us-gaap Net Income Loss
NetIncomeLoss
5077920
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20000
CY2021 dhcau Cash Paid In Excess Of Fair Value For Private Warrants
CashPaidInExcessOfFairValueForPrivateWarrants
3133522
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27136138
CY2021 us-gaap Net Income Loss
NetIncomeLoss
5077920
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18904696
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4462497
CY2022 us-gaap Net Income Loss
NetIncomeLoss
7206713
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-16160480
CY2022 us-gaap Profit Loss
ProfitLoss
7206713
CY2021 us-gaap Profit Loss
ProfitLoss
5077920
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
4462497
CY2021 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8135024
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7977190
CY2022 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021 dhcau Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
586339
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1500
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-327136
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
361866
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4416306
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1024627
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-648866
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1650170
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
309450720
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-309450720
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
303261706
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
9189015
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
171357
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
317000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311962364
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-648866
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
861474
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
861474
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212608
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
861474
CY2022 dhcau Offering Costs Paid Through Promissory Note
OfferingCostsPaidThroughPromissoryNote
0
CY2021 dhcau Offering Costs Paid Through Promissory Note
OfferingCostsPaidThroughPromissoryNote
130916
CY2022 dhcau Payment Of Prepaid Expenses Through Promissory Note
PaymentOfPrepaidExpensesThroughPromissoryNote
0
CY2021 dhcau Payment Of Prepaid Expenses Through Promissory Note
PaymentOfPrepaidExpensesThroughPromissoryNote
26800
CY2022 dhcau Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
0
CY2021 dhcau Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
10830775
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
89
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-12-22
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
300000000
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
9450720
CY2022Q4 dhcau Assets Deposited In Trust Noncurrent
AssetsDepositedInTrustNoncurrent
309450720
CY2022Q4 dhcau Transaction Cost
TransactionCost
17501346
CY2021Q1 dhcau Cash Underwriting Fess Net Of Reimbursement
CashUnderwritingFessNetOfReimbursement
6189014
CY2022Q4 dhcau Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
10830775
CY2022Q4 dhcau Other Offering Costs Payable
OtherOfferingCostsPayable
481557
CY2022Q4 dhcau Percentage Of Asset Held In Trust Account
PercentageOfAssetHeldInTrustAccount
0.80
CY2022Q4 dhcau Net Tangible Assets Required For Consummation Of Business Combination
NetTangibleAssetsRequiredForConsummationOfBusinessCombination
5000001
CY2022 dhcau Dissolution Expenses
DissolutionExpenses
100000
CY2022Q4 us-gaap Cash
Cash
212608
CY2022Q4 dhcau Working Capital
WorkingCapital
5165295
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. </div>
CY2022 dhcau Future Confirming Events
FutureConfirmingEvents
one or more future confirming events
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
9450720
CY2022Q4 dhcau Assets Deposited In Trust Noncurrent
AssetsDepositedInTrustNoncurrent
309450720
CY2022 dhcau Number Of Days After The Completion Of The Business Combination Termination Of The Applicable Lockup Period Occurs
NumberOfDaysAfterTheCompletionOfTheBusinessCombinationTerminationOfTheApplicableLockupPeriodOccurs
P30D
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3554928
CY2022Q4 dhcau Deferred Underwriting Fee Payable Per Unit
DeferredUnderwritingFeePayablePerUnit
0.35
CY2022Q4 dhcau Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
10830775
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 dhcau Number Of Days After Consummation Of Business Combination Within Which Securities Registration Shall Become Effective
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBecomeEffective
P60D
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
313913217
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
309450720

Files In Submission

Name View Source Status
0001193125-23-085720-index-headers.html Edgar Link pending
0001193125-23-085720-index.html Edgar Link pending
0001193125-23-085720.txt Edgar Link pending
0001193125-23-085720-xbrl.zip Edgar Link pending
d414388d10k.htm Edgar Link pending
d414388dex311.htm Edgar Link pending
d414388dex312.htm Edgar Link pending
d414388dex321.htm Edgar Link pending
d414388dex322.htm Edgar Link pending
d414388dex45.htm Edgar Link pending
dhcau-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dhcau-20221231_cal.xml Edgar Link unprocessable
dhcau-20221231_lab.xml Edgar Link unprocessable
dhcau-20221231_def.xml Edgar Link unprocessable
dhcau-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d414388d10k_htm.xml Edgar Link completed